Literature DB >> 6219223

Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.

R R Tidwell, J D Geratz, E J Dubovi.   

Abstract

Two series of amidine derivatives consisting of a total of 24 compounds were examined for a correlation between their blocking effect on respiratory syncytial virus induced cell fusion and their inhibitory activity against selected trypsin-like protease. Although no correlation was evident between the two activities, several potentially important discoveries were made. A highly selective inhibitor of plasmin over thrombin (compound 10) was obtained, and a potent new blocker of virus-induced cell fusion (compound 22) was identified.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219223     DOI: 10.1021/jm00356a036

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.

Authors:  M K Pastey; J E Crowe; B S Graham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

Authors:  S Sperl; U Jacob; N Arroyo de Prada; J Stürzebecher; O G Wilhelm; W Bode; V Magdolen; R Huber; L Moroder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses.

Authors:  R H Yolken; R Willoughby; S B Wee; R Miskuff; S Vonderfecht
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

4.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

5.  Effect of synthetic protease inhibitors of the amidine type on cell injury by Rickettsia rickettsii.

Authors:  D H Walker; R R Tidwell; T M Rector; J D Geratz
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition.

Authors:  C A Bell; C C Dykstra; N A Naiman; M Cory; T A Fairley; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells.

Authors:  C C Dykstra; D R McClernon; L P Elwell; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.

Authors:  J C Jennette; R R Tidwell; J D Geratz; D H Bing; R J Falk
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

9.  Orally active fusion inhibitor of respiratory syncytial virus.

Authors:  Christopher Cianci; Kuo-Long Yu; Keith Combrink; Ny Sin; Bradley Pearce; Alan Wang; Rita Civiello; Stacey Voss; Guangxiang Luo; Kathy Kadow; Eugene V Genovesi; Brian Venables; Hatice Gulgeze; Ashok Trehan; Jennifer James; Lucinda Lamb; Ivette Medina; Julia Roach; Zheng Yang; Lisa Zadjura; Richard Colonno; Junius Clark; Nicholas Meanwell; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

10.  Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.

Authors:  C Conti; P Tomao; D Genovese; N Desideri; M L Stein; N Orsi
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.